1. Home
  2. GHRS vs HTBK Comparison

GHRS vs HTBK Comparison

Compare GHRS & HTBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • HTBK
  • Stock Information
  • Founded
  • GHRS 2018
  • HTBK 1997
  • Country
  • GHRS Ireland
  • HTBK United States
  • Employees
  • GHRS N/A
  • HTBK N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • HTBK Major Banks
  • Sector
  • GHRS Health Care
  • HTBK Finance
  • Exchange
  • GHRS Nasdaq
  • HTBK Nasdaq
  • Market Cap
  • GHRS 583.1M
  • HTBK 557.0M
  • IPO Year
  • GHRS 2021
  • HTBK 1998
  • Fundamental
  • Price
  • GHRS $10.60
  • HTBK $9.20
  • Analyst Decision
  • GHRS Strong Buy
  • HTBK Buy
  • Analyst Count
  • GHRS 8
  • HTBK 3
  • Target Price
  • GHRS $30.63
  • HTBK $11.33
  • AVG Volume (30 Days)
  • GHRS 146.4K
  • HTBK 305.0K
  • Earning Date
  • GHRS 05-08-2025
  • HTBK 04-24-2025
  • Dividend Yield
  • GHRS N/A
  • HTBK 5.65%
  • EPS Growth
  • GHRS N/A
  • HTBK N/A
  • EPS
  • GHRS N/A
  • HTBK 0.68
  • Revenue
  • GHRS N/A
  • HTBK $174,083,000.00
  • Revenue This Year
  • GHRS N/A
  • HTBK $9.66
  • Revenue Next Year
  • GHRS N/A
  • HTBK $4.72
  • P/E Ratio
  • GHRS N/A
  • HTBK $13.68
  • Revenue Growth
  • GHRS N/A
  • HTBK N/A
  • 52 Week Low
  • GHRS $6.00
  • HTBK $7.74
  • 52 Week High
  • GHRS $20.50
  • HTBK $11.27
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 59.36
  • HTBK 53.41
  • Support Level
  • GHRS $9.81
  • HTBK $9.14
  • Resistance Level
  • GHRS $11.50
  • HTBK $9.38
  • Average True Range (ATR)
  • GHRS 0.72
  • HTBK 0.22
  • MACD
  • GHRS 0.23
  • HTBK 0.07
  • Stochastic Oscillator
  • GHRS 89.60
  • HTBK 70.15

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

Share on Social Networks: